BioNTech Initiates Phase 1 Clinical Trial for Malaria
BioNTech aims to develop the first mRNA-based vaccine for Malaria prevention based on a novel multi-antigen vaccine approachFirst evaluated candidate...
United States Sylke Maas Fosun Pharma World Health Organization Roche Group Africa Centers For Disease
Source: globenewswire.com